Overview

Pilot Study on the Use of Acitretin for the Treatment of Severe Chronic Hand Dermatitis

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
This pilot, phase II, 24-week study will recruit a total of 10 patients and will evaluate the efficacy and safety of acitretin in patients with severe chronic hand dermatitis .
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Innovaderm Research Inc.
Collaborator:
Tribute Pharmaceuticals
Treatments:
Acitretin